in vitro and in vivo be approaches: challenges and opportunities – session 3b
Published 3 years ago • 1.2K plays • Length 1:16:01Download video MP4
Download video MP3
Similar videos
-
1:14:28
in vitro and in vivo be approaches: challenges and opportunities – session 3a
-
20:46
in vitro studies for alternative be approaches to comparative clinical endpoint be studies
-
30:26
in vitro and in vivo abuse deterrence evaluation of generic opioids (30of39) complex generics 2018
-
20:45
in vitro bioequivalence studies of topical drug products: challenges and promises of ivrt and ivpt
-
23:52
in vivo dermal microperfusion & microdialysis bioequivalence approaches
-
21:19
addressing common challenges in be studies due to covid-19: ogd’s approach
-
0:37
marty makary for fda commish?!?!
-
18:47
challenges in generic drug safety and surveillance (6of27) generic drugs forum 2018
-
20:11
topical dosage forms: emerging insights and implications for bioequivalence approaches
-
1:50:00
advancing generic drug development: translating science to approval – day 2 – session 7
-
2:57:33
a deep dive: gdufa iii scientific meetings
-
1:16:04
fda nanoday symposium 2022 session 2
-
0:16
what is fda’s role in regulating drugs? (15 seconds)
-
17:43
bioavailability/bioequivalence site evaluation during the pandemic
-
14:52
postmarketing safety and surveillance of generic drugs update
-
1:01:47
conversations on cancer program, pazdur 25—celebrating a silver fda anniversary
-
1:22:09
generic industry challenge perspectives - gdufa science and research initiatives public workshop
-
1:56:38
fda nanoday 2022 session 3
-
1:07:41
generic drugs forum 2022 – day 1, session 3